MIAMI: For the first time, researchers have identified a gene mutation that’s directly linked with the development of multiple sclerosis (MS), a difficult-to-diagnose neurodegenerative disease that affects about 2.3 million people worldwide. Those findings may enable earlier diagnosis and intervention, as well as aid the Read More »

NEW YORK: Blood serum levels of progranulin, a key protein to both neuronal survival and neurodegenerative diseases, are not adequate measures of progranulin levels in the brain. As such, they cannot serve as a biomarker for diseases ranging from Alzheimer’s to amyotrophic lateral sclerosis (ALS), researchers Read More »

LOS ANGELES: Biomarkers could revolutionise the early detection of and therapy for Alzheimer’s disease. However, experts attending the Congress of the European Academy of Neurology (EAN) in Copenhagen criticised that the big breakthroughs are slow in coming because of a lack of priorities in research. A Read More »

DALLAS: A Johns Hopkins study on data from more than 7,000 older Americans has found that those who show signs of probable dementia but are not yet formally diagnosed are nearly twice as likely as those with such a diagnosis to engage in potentially unsafe Read More »